In 2023, the Italian government expenditure on R&D in medical and health sciences likely stood lower than the forecasted 876.4 million Euros for 2024. Forecast data indicate a steady upward trajectory through to 2028, with year-on-year growth rates averaging around 2% to 2.13%. The compounded annual growth rate (CAGR) for this period averages at approximately 2.09%, signifying consistent, incremental increases in funding commitment.

Future trends to watch for include:

An increase in strategic public-private partnerships to boost R&D efficiency and output.
Adoption of innovative technologies such as AI and biosensors within R&D processes.
A potential rise in funding as the importance of health research grows in response to global health challenges.